logo
ResearchBunny Logo
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

Medicine and Health

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

K. Shitara, K. Muro, et al.

This groundbreaking study by Kohei Shitara and colleagues reveals how circulating tumor DNA (ctDNA) gene alterations can influence the treatment efficacy in patients with metastatic colorectal cancer. The research highlights the potential of ctDNA to guide treatment decisions, showing improved survival rates with specific therapies based on gene alteration status.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny